Enhanced external counterpulsation
Results: 5
| # | Item |
|---|---|
1 | Microsoft Word - NCHC Enhanced External Counterpulsation _EECP_ Policy Public Comment.docAdd to Reading ListSource URL: www.ncdhhs.govLanguage: English - Date: 2012-02-29 09:12:32 |
2![FDA Executive Summary Prepared for the December 5, 2012 meeting of the Circulatory System Devices Panel Classification of External Counter-Pulsating (ECP) Devices (21 CFR[removed])](https://www.pdfsearch.io/img/e06d5b0ed4d9148bd9ea1fae52b7fdc7.jpg "FDA Executive Summary Prepared for the December 5, 2012 meeting of the Circulatory System Devices Panel Classification of External Counter-Pulsating (ECP) Devices (21 CFR[removed])") | FDA Executive Summary Prepared for the December 5, 2012 meeting of the Circulatory System Devices Panel Classification of External Counter-Pulsating (ECP) Devices (21 CFR[removed])Add to Reading ListSource URL: www.fda.govLanguage: English |
3![Microsoft PowerPoint - FDA Slide Set-515i IABP[removed]final.pptx](https://www.pdfsearch.io/img/0edbe7dc5b9c7885b130bcebb0783922.jpg "Microsoft PowerPoint - FDA Slide Set-515i IABP[removed]final.pptx") | Microsoft PowerPoint - FDA Slide Set-515i IABP[removed]final.pptxAdd to Reading ListSource URL: www.fda.govLanguage: English |
4 | Decision Memo for External Counterpulsation (ECP) Therapy (CAG-00002R)Add to Reading ListSource URL: www.fda.govLanguage: English |
5 | (OTC BB: VASO) A GLOBAL LEADER IN NON INVASIVE HEALTHCARE Company DescriptionAdd to Reading ListSource URL: www.vasomedical.comLanguage: English - Date: 2013-12-03 12:40:30 |